234 related articles for article (PubMed ID: 23744076)
1. Cyclin-dependent kinase 9 links RNA polymerase II transcription to processing of ribosomal RNA.
Burger K; Mühl B; Rohrmoser M; Coordes B; Heidemann M; Kellner M; Gruber-Eber A; Heissmeyer V; Strässer K; Eick D
J Biol Chem; 2013 Jul; 288(29):21173-21183. PubMed ID: 23744076
[TBL] [Abstract][Full Text] [Related]
2. T-loop phosphorylated Cdk9 localizes to nuclear speckle domains which may serve as sites of active P-TEFb function and exchange between the Brd4 and 7SK/HEXIM1 regulatory complexes.
Dow EC; Liu H; Rice AP
J Cell Physiol; 2010 Jul; 224(1):84-93. PubMed ID: 20201073
[TBL] [Abstract][Full Text] [Related]
3. RNA helicase DDX21 coordinates transcription and ribosomal RNA processing.
Calo E; Flynn RA; Martin L; Spitale RC; Chang HY; Wysocka J
Nature; 2015 Feb; 518(7538):249-53. PubMed ID: 25470060
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of P-TEFb disrupts global transcription, oocyte maturation, and embryo development in the mouse.
Oqani RK; Lin T; Lee JE; Kim SY; Sa SJ; Woo JS; Jin DI
Genesis; 2016 Sep; 54(9):470-82. PubMed ID: 27488304
[TBL] [Abstract][Full Text] [Related]
5. CDK9 inhibition strategy defines distinct sets of target genes.
Garriga J; Graña X
BMC Res Notes; 2014 May; 7():301. PubMed ID: 24886624
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of CDK9 kinase activity and Mcl-1 stability contributes to the acquired resistance to cyclin-dependent kinase inhibitors in leukemia.
Yeh YY; Chen R; Hessler J; Mahoney E; Lehman AM; Heerema NA; Grever MR; Plunkett W; Byrd JC; Johnson AJ
Oncotarget; 2015 Feb; 6(5):2667-79. PubMed ID: 25596730
[TBL] [Abstract][Full Text] [Related]
7. A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects (TEdeff) in Cancers.
Modur V; Singh N; Muhammad B
J Vis Exp; 2019 Sep; (151):. PubMed ID: 31609304
[TBL] [Abstract][Full Text] [Related]
8. Mammalian DEAD box protein Ddx51 acts in 3' end maturation of 28S rRNA by promoting the release of U8 snoRNA.
Srivastava L; Lapik YR; Wang M; Pestov DG
Mol Cell Biol; 2010 Jun; 30(12):2947-56. PubMed ID: 20404093
[TBL] [Abstract][Full Text] [Related]
9. CDK9 keeps RNA polymerase II on track.
Egloff S
Cell Mol Life Sci; 2021 Jul; 78(14):5543-5567. PubMed ID: 34146121
[TBL] [Abstract][Full Text] [Related]
10. The functional role of an interleukin 6-inducible CDK9.STAT3 complex in human gamma-fibrinogen gene expression.
Hou T; Ray S; Brasier AR
J Biol Chem; 2007 Dec; 282(51):37091-102. PubMed ID: 17956865
[TBL] [Abstract][Full Text] [Related]
11. The CDK9/cyclin T1 subunits of P-TEFb in mouse oocytes and preimplantation embryos: a possible role in embryonic genome activation.
Oqani RK; Kim HR; Diao YF; Park CS; Jin DI
BMC Dev Biol; 2011 Jun; 11():33. PubMed ID: 21639898
[TBL] [Abstract][Full Text] [Related]
12. The Establishment of a Hyperactive Structure Allows the Tumour Suppressor Protein p53 to Function through P-TEFb during Limited CDK9 Kinase Inhibition.
Albert TK; Antrecht C; Kremmer E; Meisterernst M
PLoS One; 2016; 11(1):e0146648. PubMed ID: 26745862
[TBL] [Abstract][Full Text] [Related]
13. SIRT7-dependent deacetylation of CDK9 activates RNA polymerase II transcription.
Blank MF; Chen S; Poetz F; Schnölzer M; Voit R; Grummt I
Nucleic Acids Res; 2017 Mar; 45(5):2675-2686. PubMed ID: 28426094
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapeutic drugs inhibit ribosome biogenesis at various levels.
Burger K; Mühl B; Harasim T; Rohrmoser M; Malamoussi A; Orban M; Kellner M; Gruber-Eber A; Kremmer E; Hölzel M; Eick D
J Biol Chem; 2010 Apr; 285(16):12416-25. PubMed ID: 20159984
[TBL] [Abstract][Full Text] [Related]
15. Acetylation of conserved lysines in the catalytic core of cyclin-dependent kinase 9 inhibits kinase activity and regulates transcription.
Sabò A; Lusic M; Cereseto A; Giacca M
Mol Cell Biol; 2008 Apr; 28(7):2201-12. PubMed ID: 18250157
[TBL] [Abstract][Full Text] [Related]
16. Camptothecin releases P-TEFb from the inactive 7SK snRNP complex.
Amente S; Gargano B; Napolitano G; Lania L; Majello B
Cell Cycle; 2009 Apr; 8(8):1249-55. PubMed ID: 19305131
[TBL] [Abstract][Full Text] [Related]
17. Coordination of transcription factor phosphorylation and histone methylation by the P-TEFb kinase during human immunodeficiency virus type 1 transcription.
Zhou M; Deng L; Lacoste V; Park HU; Pumfery A; Kashanchi F; Brady JN; Kumar A
J Virol; 2004 Dec; 78(24):13522-33. PubMed ID: 15564463
[TBL] [Abstract][Full Text] [Related]
18. Flavopiridol inactivates P-TEFb and blocks most RNA polymerase II transcription in vivo.
Chao SH; Price DH
J Biol Chem; 2001 Aug; 276(34):31793-9. PubMed ID: 11431468
[TBL] [Abstract][Full Text] [Related]
19. Cyclin K functions as a CDK9 regulatory subunit and participates in RNA polymerase II transcription.
Fu TJ; Peng J; Lee G; Price DH; Flores O
J Biol Chem; 1999 Dec; 274(49):34527-30. PubMed ID: 10574912
[TBL] [Abstract][Full Text] [Related]
20. Flavopiridol induces phosphorylation of AKT in a human glioblastoma cell line, in contrast to siRNA-mediated silencing of Cdk9: Implications for drug design and development.
Caracciolo V; Laurenti G; Romano G; Carnevale V; Cimini AM; Crozier-Fitzgerald C; Gentile Warschauer E; Russo G; Giordano A
Cell Cycle; 2012 Mar; 11(6):1202-16. PubMed ID: 22391209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]